San Francisco, CA (UroToday.com) – The Answer Cancer Foundation (AnCan) and Us Too International, which sponsor support groups for men with prostate cancer, announced a series of four webinars, Active Surveillance and Beyond, aimed at men on or considering active surveillance (AS) for low- and intermediate-risk prostate cancer in place of aggressive therapy.